Step 1 topics → Gastrointestinal → Achalasia

Achalasia

USMLE Step 1 trap: Attributes achalasia to LES muscle hypertrophy rather than loss of inhibitory myenteric neurons. Achalasia is caused by loss of inhibitory (nitric oxide/VIP-releasing) myenteric neurons in the esophageal body and LES, resulting in failure of LES relaxation and absent peristalsis.

Achalasia is tested on USMLE Step 1 at multiple levels, and two traps catch students repeatedly. First, the LES in achalasia is not hypertrophied or structurally abnormal — it's neurologically disinhibited because the inhibitory Auerbach plexus neurons (which release nitric oxide and VIP) are gone. Second, manometry requires two findings to confirm the diagnosis — incomplete LES relaxation AND absent peristalsis — and students who only remember 'absent peristalsis' will miss the requirement for both. The long-term complication of untreated achalasia is squamous cell carcinoma, not adenocarcinoma, because the mechanism is chronic stasis and mucosal irritation, not acid reflux.

What makes achalasia tricky is that students often confuse the mechanism with the consequence. The LES is NOT hypertrophied or structurally abnormal — it's neurologically disinhibited. This distinction matters because Step 1 loves to test whether you understand why the LES fails (lost inhibitory neurons), not just that it fails. Similarly, manometry is the gold standard and has two required findings — students who only remember 'absent peristalsis' will miss that incomplete LES relaxation is equally essential to the diagnosis.

The two high-yield traps are pseudoachalasia and cancer risk. An older patient with rapid-onset dysphagia and identical manometry findings should make you think GEJ adenocarcinoma, not primary achalasia. And if a question gives you a patient with long-standing untreated achalasia and asks about complications, the answer is squamous cell carcinoma — not adenocarcinoma, not Barrett's — because the mechanism is chronic stasis and mucosal irritation, not acid reflux. USMLE Step 1 rewards students who can distinguish these nuances from the surface-level facts.

From real student decks
84%have cards covering this topic
62%have mature cards

Common misconceptions

Common mistake
Wrong: Achalasia is caused by hypertrophy of the LES smooth muscle.
Right: Achalasia is caused by loss of inhibitory (nitric oxide/VIP-releasing) myenteric neurons in the esophageal body and LES, resulting in failure of LES relaxation and absent peristalsis.
The LES in achalasia is not structurally hypertrophied — it's functionally stuck in contraction because the inhibitory neurons that normally tell it to relax are gone. Nitric oxide and VIP released by Auerbach plexus neurons are what cause smooth muscle relaxation after a swallow; when those neurons are lost, the LES has no 'off switch.' Calling it hypertrophy implies a structural problem you could see on biopsy, when the real lesion is neuronal dropout — this distinction is exactly what Step 1 tests.
Common mistake
Wrong: Achalasia shows normal LES relaxation on manometry with absent peristalsis.
Right: Achalasia shows incomplete LES relaxation with swallowing AND absent peristalsis in the esophageal body on manometry.
Manometry in achalasia has two mandatory findings, not one: incomplete LES relaxation with swallowing AND absent peristalsis in the esophageal body. Either finding alone is insufficient for the diagnosis. Absent peristalsis without LES dysfunction could suggest another motility disorder; LES dysfunction without absent peristalsis would point elsewhere. The exam will give you manometry data and expect you to check both criteria before confirming achalasia.
Common mistake
Gap: Overlooks pseudoachalasia from GEJ malignancy as a mimic of primary achalasia requiring exclusion
Pseudoachalasia (secondary achalasia) caused by malignancy at the gastroesophageal junction can mimic primary achalasia on manometry and must be excluded, especially in older patients with rapid symptom onset.
GEJ adenocarcinoma can infiltrate the myenteric plexus and produce identical manometry findings to primary achalasia — this is pseudoachalasia, and missing it is a serious clinical error. The key red flags are older age at onset (primary achalasia typically presents in younger adults) and rapid progression of dysphagia (weeks to months rather than years). Whenever a Step 1 vignette hints at these features, the correct next step is endoscopy or CT to rule out malignancy before accepting a diagnosis of primary achalasia.
Common mistake
Gap: Unaware that untreated achalasia carries a long-term risk of esophageal squamous cell carcinoma
Long-standing achalasia increases the risk of esophageal squamous cell carcinoma due to chronic stasis and mucosal irritation from retained food.
Long-standing achalasia raises the risk of esophageal squamous cell carcinoma — not adenocarcinoma. The mechanism is chronic retention of food and secretions causing prolonged mucosal irritation in the esophageal body, which drives squamous dysplasia over time. This is fundamentally different from Barrett's esophagus-related adenocarcinoma, which is driven by acid reflux. Since achalasia actually reduces acid exposure (the closed LES blocks reflux), adenocarcinoma is not the complication to expect.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Identify the specific neuronal loss responsible for achalasia — loss of inhibitory (NO/VIP-releasing) myenteric neurons in the Auerbach plexus — and explain why this causes both LES failure to relax and absent peristalsis
  2. Interpret manometry findings in achalasia: recognize that BOTH incomplete LES relaxation with swallowing AND absent peristalsis in the esophageal body are required findings, not just one
  3. Recognize pseudoachalasia from GEJ malignancy as a clinical and manometric mimic of primary achalasia, and identify the features (older age, rapid symptom onset) that should trigger further workup to exclude it
  4. Identify the long-term complication of untreated achalasia as esophageal squamous cell carcinoma and explain why (chronic food stasis and mucosal irritation, not acid exposure)
  5. Select appropriate management options for achalasia, distinguishing definitive treatments (pneumatic dilation, Heller myotomy, POEM) from temporizing measures (calcium channel blockers, nitrates, botulinum toxin injection)

Can you avoid these mistakes?

A 35-year-old has progressive dysphagia to solids and liquids. Manometry shows LES pressure of 45 mmHg (elevated) with 30% relaxation on swallowing and no peristaltic contractions. What is the diagnosis, and what two manometric findings confirm it?
A 70-year-old presents with a 3-month history of rapidly worsening dysphagia. Manometry findings are indistinguishable from achalasia. What diagnosis must be excluded before attributing this to primary achalasia, and what is the next best step?
A patient with achalasia diagnosed 20 years ago never pursued treatment. He now presents with weight loss and a new esophageal mass on imaging. What type of cancer is he at increased risk for, and what is the underlying mechanism — why is it this type and not adenocarcinoma?
A patient with achalasia wants to know her options. Which treatments are definitive (aimed at permanently reducing LES pressure) versus temporizing? Name at least one of each and explain the mechanism of the definitive option.

Related topics

Gut Tube Regions and Blood Supply Midgut Rotation and Anomalies (Malrotation/Volvulus) Meckel Diverticulum Omphalocele vs Gastroschisis

See how your Anki deck covers this topic.

Upload your deck for a free audit →